People living with generalised myasthenia gravis (gMG) who are interested in learning more about clinical research opportunities can now enquire about the MyClad Study, with all recruitment sites and participating hospitals now open for enquiries.
The MyClad Study is a clinical research study evaluating an investigational medication taken by mouth for people living with gMG.
Interested in the MyClad Study? Explore Your Options
With recruitment sites now open, people interested in the study can visit the MyClad Study website to explore participating locations and learn more about their options.
The study website provides information about:
- what the MyClad Study is and the investigational medication being researched
- who may be eligible to take part
- what participants can expect during the study
- frequently asked questions about clinical research
- participating study locations across Australia
The website also includes a study location search, allowing visitors to enter their postcode and find a participating location near them.
Could You Take Part in the MyClad Study?
You may be eligible to participate in the MyClad Study if you:
✓ are an adult 18 years of age or older
✓ have a confirmed diagnosis of myasthenia gravis (MG) with generalised muscle weakness
Other eligibility criteria apply and the study team can provide further information about whether the study may be suitable for you.
Find Out More About the MyClad Study
If you are living with generalised myasthenia gravis and are interested in learning more about this clinical research study, now is the time to explore your options.
Visit the MyClad Study website to learn more about the study, view participating locations and find contact information for recruitment sites.
Participation in a clinical research study is voluntary. Eligibility criteria apply.